2025
SJR Q1
JCR Q3 · 2
54 matched articles
SCIE
Journal detail
Pregnancy Hypertension
- Publisher
- Elsevier B.V.
- Country
- Netherlands · Western Europe
- Type
- journal
- ISSN
-
2210778922107797
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 1,314
- Quartile Q1
- H-Index 47
- Cites/doc 1,91
- Docs (3y) 252
- Cites (3y) 924
Clarivate
Web of Science · JCR · 2025
- JCR Q Q3
- JIF 2
- 5Y JIF 3,3
- JCI 0,87
WoS indexes
- SCIE
Subject classification
Categories (SJR)
Areas
WoS categories
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q1 | Q3 | 1,314 | 2 | 3,3 | 0,87 | Q2 | 47 |
| 2024 | Q1 | Q1 | 1,102 | 2,9 | 2,6 | 0,84 | Q1 | 43 |
| 2023 | Q1 | Q2 | 0,954 | 2,5 | 2,6 | 0,78 | Q2 | 43 |
| 2022 | Q1 | Q3 | 0,868 | 2,2 | 2,7 | 0,66 | Q2 | 43 |
| 2021 | Q1 | Q3 | 0,95 | 2,5 | 2,9 | 0,73 | Q2 | 43 |
| 2020 | Q1 | Q2 | 1,104 | 2,9 | 2,9 | 0,72 | Q2 | 43 |
| 2019 | Q2 | Q3 | 0,844 | 2,1 | 2,8 | 0,7 | Q2 | 43 |
| 2018 | — | Q3 | — | 2 | 3,2 | 0,56 | Q3 | — |
| 2017 | Q1 | Q3 | 1,205 | 2 | 2,9 | 0,53 | Q3 | 43 |
| 2016 | Q2 | Q1 | 1,008 | 3,9 | 2,8 | — | — | 43 |
| 2015 | Q2 | Q4 | 0,64 | 1,3 | 1,3 | — | — | 43 |
| 2014 | Q2 | — | 0,501 | — | — | — | — | 43 |
| 2013 | Q2 | — | 0,359 | — | — | — | — | 43 |
| 2012 | Q3 | — | 0,285 | — | — | — | — | 43 |
| 2011 | — | — | — | — | — | — | — | 43 |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q2 | 78/143 |
| 2025 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q2 | 63/100 |
| 2024 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | Q2 | 26/141 |
| 2024 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q1 | 34/98 |
| 2023 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | Q2 | 45/136 |
| 2023 | PERIPHERAL VASCULAR DISEASE | SCIE | Q2 | Q2 | 42/96 |
| 2022 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q3 | 55/85 |
| 2022 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q2 | 49/68 |
| 2021 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q2 | 57/85 |
| 2021 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q2 | 48/67 |
| 2020 | OBSTETRICS & GYNECOLOGY | SCIE | Q2 | Q3 | 37/83 |
| 2020 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q2 | 34/65 |
| 2019 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q2 | 42/82 |
| 2019 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q2 | 42/65 |
| 2018 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q3 | 47/83 |
| 2018 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 42/65 |
| 2017 | OBSTETRICS & GYNECOLOGY | SCIE | Q3 | Q3 | 44/82 |
| 2017 | PERIPHERAL VASCULAR DISEASE | SCIE | Q3 | Q3 | 44/65 |
| 2016 | OBSTETRICS & GYNECOLOGY | SCIE | Q1 | — | 9/80 |
| 2016 | PERIPHERAL VASCULAR DISEASE | SCIE | Q1 | — | 14/63 |
| 2015 | OBSTETRICS & GYNECOLOGY | SCIE | Q4 | — | 61/80 |
| 2015 | PERIPHERAL VASCULAR DISEASE | SCIE | Q4 | — | 53/63 |